GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 130,500
+3,400 (2.68%)
Aug 28, 2026, 3:30 PM KST
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.45 trillion as of August 28, 2026. Its market cap has decreased by -4.51% in one year.
Market Cap
1.45T
Enterprise Value
2.40T
Revenue
2.04T
Ranking
n/a
PE Ratio
n/a
Stock Price
130,500.00
ChartMarket Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.45T, an increase of 4,887.35%. That is a compound annual growth rate of 13.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 1.49T | -17.92% |
| Dec 30, 2025 | 1.81T | -11.42% |
| Dec 30, 2024 | 2.05T | 43.03% |
| Dec 28, 2023 | 1.43T | -3.09% |
| Dec 29, 2022 | 1.48T | -40.60% |
| Dec 30, 2021 | 2.49T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanall Biopharma | 3.28T |
| Celltrion Pharm | 1.86T |
| Daewoong Pharmaceutical | 1.48T |
| Chong Kun Dang Pharmaceutical | 902.56B |
| Daewoong | 756.24B |
| Boryung | 751.88B |
| JW Pharmaceutical | 616.53B |
| Dong-A Socio Holdings | 611.17B |